NCT07435129 Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD Status NOT_YET_RECRUITING Phase PHASE2
NCT07409142 BetterLife FSHD: A Patient-driven Health and Research Platform Status RECRUITING Phase N/A
NCT07331025 Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings Status COMPLETED Phase N/A
NCT07038200 A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD Status RECRUITING Phase PHASE3
NCT06907875 A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy Status RECRUITING Phase PHASE1/PHASE2
NCT06708468 Personalized Training for People With Rare Neuromuscular Disorders Status RECRUITING Phase NA
NCT06086548 Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics Status NOT_YET_RECRUITING Phase N/A
NCT05453461 ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT05178706 Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia) Status COMPLETED Phase N/A
NCT04001582 The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry Status RECRUITING Phase N/A
NCT03943290 Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) Status TERMINATED Phase PHASE2
NCT03458832 Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02927080 Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) Status TERMINATED Phase PHASE2
NCT02836418 Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) Status COMPLETED Phase PHASE1/PHASE2